Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00870961 · ClinicalTrials.gov registry record · NA

Vitamin D Supplement in Preventing Colon Cancer in African Americans With Colon Polyps

A NA study, sponsored by Northwestern University.

Terminated
Registry status
NA
Development phase
22
Enrollment target

NCT00870961: Clinical Trial NA study, sponsored by Northwestern University.

NCT00870961 is a NA study that was terminated before completion, run by Northwestern University. The registered enrollment target is 22 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00870961, a NA study, was terminated before completion, sponsored by Northwestern University.

TERMINATED
Registry status
NA
Development phase
22 participants
Enrollment target

Study Summary

RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming. The use of vitamin D may keep colorectal cancer from forming in patients with colon polyps. PURPOSE: This randomized phase I trial is studying a vitamin D supplement to see how well it works compared with a placebo in preventing colorectal cancer in African Americans with colon polyps.

Interventions

  • OTHER placebo
  • DIETARY_SUPPLEMENT cholecalciferol

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2009-02
Est. Completion 2012-06
Phase NA
Northwestern University

1,209 total trials

Why NCT00870961 stopped before completion

NCT00870961 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.

NCT00870961 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00870961 about?

NCT00870961 is a clinical study titled "Vitamin D Supplement in Preventing Colon Cancer in African Americans With Colon Polyps". RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming. The use of vitamin D may keep colorectal cancer from forming in patients with colon polyps. PURPOSE: This randomized phase I trial is studying a vitamin D supplement to see how well it works compared with a placebo ...

What is the current status of trial NCT00870961?

This trial is currently terminated. It is a NA study. The enrollment target is 22 participants. The study started on 2009-02. Estimated completion is 2012-06.

What interventions are being tested in trial NCT00870961?

The interventions under investigation include: placebo (OTHER), cholecalciferol (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00870961?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00870961's enrollment target sits among peer trials

22 1756th of 2000 higher than 239 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02508038 · 22 participants · Phase 1

    Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

  • NCT03099356 · 22 participants · Phase 2

    Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

  • NCT03676647 · 22 participants

    Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules

  • NCT04569591 · 22 participants · NA

    DDAVP for Pituitary Adenoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00870961, the US trial registry maintained by the National Library of Medicine. NCT00870961 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.